Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane...

por Kevin Roedl, Ahmel Kahn, Dominik Jarczak, Marlene Fischer, Olaf Boenisch, Geraldine de Heer, Christoph Burdelski, Daniel Frings, Barbara Sensen, Axel Nierhaus, Stephan Braune, Yalin Yildirim, Alexander Bernhardt, Hermann Reichenspurner, Stefan Kluge, Dominic Wichmann
Publicado 2021

Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza

por Thomas Theo Brehm, Marc van der Meirschen, Annette Hennigs, Kevin Roedl, Dominik Jarczak, Dominic Wichmann, Daniel Frings, Axel Nierhaus, Tim Oqueka, Walter Fiedler, Maximilian Christopeit, Christian Kraef, Alexander Schultze, Marc Lütgehetmann, Marylyn M Addo, Stefan Schmiedel, Stefan Kluge, Julian Schulze zur Wiesch
Publicado 2021

Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blin...

por Michael Bauer, MD, Andreas Weyland, MD, Gernot Marx, MD, Frank Bloos, MD, PhD, Stephan Weber, Dipl. Stat., Norbert Weiler, MD, Stefan Kluge, MD, Anja Diers, MD, Tim Philipp Simon, MD, Ingmar Lautenschläger, MD, Matthias Gründling, MD, Ulrich Jaschinski, MD, Philipp Simon, MD, Axel Nierhaus, MD, Onnen Moerer, MD, Lorenz Reill, MD, Achim Jörres, MD, Renfeng Guo, MD, Markus Loeffler, MD, Konrad Reinhart, MD, Niels Riedemann, MD, for the SepNet-Study Group
Publicado 2021